Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampicin-resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07675954
What this trial is testing

A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis

Who this might be right for
Rifampicin-Resistant Tuberculosis
Seoul National University Hospital 294
Not applicableUnknownNCT04545788
What this trial is testing

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Who this might be right for
Tuberculosis
Beijing Chest Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06441006
What this trial is testing

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco 400
Post-approval studies (Phase 4)UnknownNCT06476210
What this trial is testing

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Who this might be right for
Pulmonary Tuberculosis
Beijing Chest Hospital 45
Not applicableStudy completedNCT04568954
What this trial is testing

TB-CAPT CORE Truenat Trial

Who this might be right for
TuberculosisDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 3,987
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Not applicableStudy completedNCT01587469
What this trial is testing

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Who this might be right for
Tuberculosis
Cepheid 992
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Testing effectiveness (Phase 2)UnknownNCT05555303
What this trial is testing

Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
Rwanda Biomedical Centre 20
Not applicableStudy completedNCT04147676
What this trial is testing

Evaluation of Centralised TB Assay Solutions

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,050
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Not applicableStudy completedNCT03044158
What this trial is testing

GeneXpert Performance Evaluation for Linkage to Tuberculosis Care

Who this might be right for
Tuberculosis, PulmonaryRifampicin Resistant Tuberculosis
University of California, San Francisco 10,644
Testing effectiveness (Phase 2)Study completedNCT03174184
What this trial is testing

Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Johns Hopkins University 112
Post-approval studies (Phase 4)Study completedNCT02231229
What this trial is testing

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Who this might be right for
Tuberculosis
Assistance Publique - Hôpitaux de Paris 204
Not applicableActive Not RecruitingNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Large-scale testing (Phase 3)Active Not RecruitingNCT06081361
What this trial is testing

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Who this might be right for
Pulmonary TuberculosisRifampicin-resistant Tuberculosis
Beijing Chest Hospital 186
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Next Page